United States of America ex rel. Steven M. Camburn et al. v. Novartis Pharmaceuticals Corporation
| 1:2013cv03700 |
| March 24, 2020 |
| US District Court for the Southern District of New York |
| Foley Square Office |
| Other Statutes: False Claims Act |
| 31 U.S.C. ยง 3729 False Claims Act |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
94
CLERK'S JUDGMENT re: 93 Memorandum & Opinion in favor of Novartis Pharmaceuticals Corporation against City of Chicago, City of New York, District of Columbia, State of California, State of Colorado, State of Connecticut, State of Delaware , State of Florida, State of Georgia, State of Hawaii, State of Illinois, State of Indiana, State of Iowa, State of Louisiana, State of Massachusetts, State of Michigan, State of Minnesota, State of Montana, State of Nevada, State of New Jersey, S tate of New Mexico, State of New York, State of North Carolina, State of Oklahoma, State of Rhode Island, State of Tennessee, State of Texas, State of Virginia, State of Washington, State of Wisconsin, United States of America, Steven M. Camburn. It is hereby ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the Court's Opinion and Order dated September 13, 2022, Novartis' motion to dismiss pursuant to Rules 12(b)(6) and 9(b) is GRANTED, and the TAC is dismissed with prejudice; accordingly, the case is closed. (Signed by Clerk of Court Ruby Krajick on 9/14/2022) (Attachments: # 1 Right to Appeal) (km)
|
|
Filing
93
OPINION AND ORDER re: 86 MOTION to Dismiss ("Notice of Novartis Pharmaceuticals Corporation's Motion to Dismiss Relator's Third Amended Complaint"). filed by Novartis Pharmaceuticals Corporation. For the foregoin g reasons, the Court GRANTS Novartis' motion to dismiss pursuant to Rules 12(b)(6) and 9(b), and the TAC is dismissed with prejudice. The Clerk is respectfully directed to close ECF No. 86 and to close the case. SO ORDERED. (Signed by Judge Kimba M. Wood on 9/13/2022) (jca) Transmission to Orders and Judgments Clerk for processing.
|
|
Filing
84
ORDER EXTENDING TIME TO RESPOND TO THIRD AMENDED COMPLAINT, SETTING A BRIEFING SCHEDULE AND EXTENDING PAGE LIMITS: it is ORDERED AS FOLLOWS: The request is GRANTED. Defendant shall respond to the Third Amended Complaint by January 3, 2022. The Court establishes the following briefing schedule and page limits with respect to any motion to dismiss the Third Amended Complaint: Defendant may file a Memorandum of Law in Support of a Motion to Dismiss the Third Amended Complaint that shall not exceed fifty (50) pages (excluding the caption, table of contents, table of authorities and signature block); Within thirty (30) days of Defendant's Motion to Dismiss, Plaintiff- Relator may file a Memorandum of Law in Opposition to Defendant's Mo tion to Dismiss that shall not exceed fifty (50) pages (excluding the caption, table of contents, table of authorities and signature block); Within fourteen (14) days of Plaintiff Relator's opposition, Defendant may file a Memorandum of Law in R eply that shall not exceed twenty (20) pages (excluding the caption, table of contents, table of authorities and signature block). SO ORDERED., Novartis Pharmaceuticals Corporation answer due 1/3/2022. (Signed by Judge Kimba M. Wood on 11/29/2021) (ama)
|
|
Filing
73
ORDER: The parties shall file a joint letter on or before December 16, 2021 detailing the status of this case and the progress of settlement negotiations. SO ORDERED. (Signed by Magistrate Judge Gabriel W. Gorenstein on 10/07/2021) (ama)
|
|
Filing
71
STIPULATED PROTECTIVE ORDER...regarding procedures to be followed that shall govern the handling of confidential material... (Signed by Magistrate Judge Gabriel W. Gorenstein on 8/4/2021) (ate)
|
|
Filing
66
MEMO ENDORSEMENT on MOTION TO WITHDRAW AS COUNSEL FOR PLAINTIFFS: granting 65 Motion for Withdraw as Counsel for Plaintiffs. ENDORSEMENT: Granted. SO ORDERED. (Signed by Judge Kimba M. Wood on 2/04/2021). *** Attorney Andrew W Ferich terminated. (ama) Modified on 2/4/2021 (ama).
|
|
Filing
61
STIPULATED CONFIDENTIALITY AGREEMENT AND PROTECTIVE ORDER...regarding procedures to be followed that shall govern the handling of confidential material... (Signed by Magistrate Judge Gabriel W. Gorenstein on 9/24/2020) (va)
|
|
Filing
59
ORDER. The above-referenced action has been referred to the undersigned for general pre-trial purposes. See 28 U.S.C. § 636(b)(1)(A). All pre-trial applications, including those relating to scheduling and discovery, shall be made to the undersi gned (except motions to dismiss or for judgment on the pleadings, for injunctive relief, for summary judgment, or for class certification). All applications must comply with this Court's Individual Practices, which are available through the Cler k's Office or at: https://nysd.uscourts.gov/hon-gabriel-w-gorenstein. All discovery (as well as requests for admissions) must be initiated in time to be concluded by the deadline for all discovery, and as further set forth in this order. SO ORDERED. (Signed by Magistrate Judge Gabriel W. Gorenstein on 9/21/20) (yv)
|
|
Filing
52
ORDER: By September 2, 2020, the parties shall submit a proposed Scheduling Order and Discovery Plan using the templates found on the Court's website and in conformity with the Court's Individual Rule and Practices and all applicable Federal Rules of Civil Procedure. SO ORDERED. (Signed by Judge Kimba M. Wood on 8/3/2020) (va)
|
|
Filing
44
OPINION & ORDER re: 28 MOTION to Dismiss ("Notice Of Novartis Pharmaceuticals Corporation's Motion To Dismiss Relator's Amended Complaint"), filed by Novartis Pharmaceuticals Corporation. For the foregoing reason s, the Court grants Novartis' motion to dismiss, pursuant to Rule 9(b), and grants Relator leave to amend his complaint by May 8, 2020, to comply with Rule 9(b)'s requirements. SO ORDERED. (Signed by Judge Kimba M. Wood on 3/24/2020) (va)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: United States of America ex rel. Steven M. Camburn et al. v. Novartis Pharmaceuticals Corporation | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
